A Randomised, Open-Label, Single-Centre, Phase I, Crossover Study to Evaluate the Effect of AZD6482, Compared With Clopidogrel, on Bleeding Time in Healthy Volunteers Receiving Low-Dose ASA.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Aspirin; AZD 6482; Clopidogrel
- Indications Acute coronary syndromes; Atherosclerosis; Ischaemic heart disorders; Myocardial infarction; Peripheral arterial occlusive disorders; Stroke; Thrombosis
- Focus Pharmacodynamics
- Sponsors AstraZeneca
- 20 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Mar 2009 New trial record